02 August 2024
Indian pharmaceutical companies are keen to localize their drug production in Russia, seeking joint ventures in the sector. This trend of establishing manufacturing bases in partner countries is seen as natural by both Indian and Russian firms, according to Mir Faruk, Vice President of the Indian Business Council and head of Ipca Laboratories’ Russian office.
“We need to move in this direction and localize production [of Indian drugs] in Russia. Especially when it comes to pharmaceutical substances, where we are very strong,” he emphasized. He noted that many Indian pharmaceutical manufacturers have already opened their sites in Russia, while others are still considering this possibility. There are also Russian entrepreneurs who want and can work in the Indian pharmaceutical market, Faruk noted.
He also said that there is potential for this. “And I think that the time has come for this, since our countries now have excellent relations at all levels. I think that the interaction of our countries in the pharmaceutical industry will continue to develop,” the agency’s interlocutor said. In 2023, India was the largest supplier of drugs to Russia (300 million packages).
PrintOctober 10 – World Mental Health Day
10 October 2024
Long-Term Game: NovaMedica Experts at the Pharma Marketing Conference
10 October 2024
NovaMedica in the TOP-1000 Russian Managers Rating
28 September 2024
Immunotherapy treatment enhances lymphoma survival, landmark study shows
21 October 2024
The Russian Ministry of Health initiates the creation of a list of key drugs
21 October 2024
DSM Group predicts the Russian pharmaceutical market will grow by 10% annually
18 October 2024
An extra 6.1 billion rubles will be allocated for drug provision in 2025
18 October 2024